Riskpilot← Back to searchSign inGet full accessNaprapatklinik018 AB
ABActiveOrg 5591842918Sleven Säfwenbergs Väg 4 BPhysiotherapy activities · NACE 8695Est. 20181-4 employees
Revenue 2024
SEK 2,5M
+2% vs 2023
EBITDA margin
5.2%
-63% vs 2023
Equity ratio
44.3%
Financial strength
Net profit 2024
SEK 85K
-67% vs 2023
| Revenue | SEK 2,5M | +2% |
| EBITDA | SEK 127K | -63% |
| Net profit | SEK 85K | -67% |
| Total assets | SEK 539K | -11% |
| Equity | SEK 239K | -32% |
| Employees | — | — |
Legal name
Naprapatklinik018 AB
Org number
5591842918
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
7 december 2018
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Att bedriva naprapati, massage, rehabilitering samt därmed förenlig verksamhet.
Address
Sleven Säfwenbergs Väg 4 B
Email
info@naprapatklinik018.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 121 | 1 791 | 2 181 | 2 405 | 2 465 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 12 | −10 | −50 | 340 | 127 |
| Depreciation & amort. | −0 | −16 | −11 | −8 | −5 |
| EBIT | 12 | −26 | −61 | 332 | 122 |
| Net financials | — | — | — | — | — |
| Profit before tax | 12 | −26 | −61 | 332 | 122 |
| Tax | −3 | −0 | −0 | −71 | −37 |
| Net profit | 9 | −26 | −61 | 261 | 85 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 365 | 276 | 287 | 609 | 539 |
| Equity | 180 | 154 | 93 | 354 | 239 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 184 | 122 | 193 | 254 | 300 |
| Total debt | 184 | 122 | 193 | 254 | 300 |
EBITDA margin
5.2%
This company
15.8%
Market median
-67% vs market
20202024
Equity ratio
44.3%
This company
38.2%
Market median
+16% vs market
20202024
Return on equity
35.6%
This company
18.4%
Market median
+93% vs market
20202024
Net profit margin
3.4%
This company
8.1%
Market median
-58% vs market
20202024
Asset turnover
4.57×
This company
1.12×
Market median
+308% vs market
20202024
Debt / equity
1.26×
This company
0.62×
Market median
-103% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KT Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Chairman | 2022 | |
| Former (2) | ||
| Board of Directors | 2022 – 2026 | |
| Board of Directors | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Naprapatklinik018 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Klara Trulsa Maria Bengtsson | Deputy Chief Executive Officer | 0 companies |
| Michael Borg | Board of Directors | 0 companies |
| Sofie Viktoria Svahn | Board of Directors | 0 companies |
| Erik Rikard Smith | Board of Directors | 0 companies |
| Hassan Aldudjaili | Chairman | 0 companies |